The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era.
Kobayashi T, Kuroda J, Yokota I, Tanba K, Fujino T, Kuwahara S, Isa R, Yamaguchi J, Kawata E, Akaogi T, Uchiyama H, Kaneko H, Uoshima N, Kobayashi Y, Teramukai S, Taniwaki M.
Kobayashi T, et al. Among authors: fujino t.
Blood Cancer J. 2016 Jan 15;6(1):e383. doi: 10.1038/bcj.2015.111.
Blood Cancer J. 2016.
PMID: 26771809
Free PMC article.
No abstract available.